Wall Street banks Goldman Sachs and Citigroup have received the H1N1 swine flu vaccine to the chagrin of many. Problem is that several healthcare facilities in New York City and around the nation have yet to receive or are running out of doses. Should companies get priority when it comes to the vaccine? Tell us what you think!